Sign In
Buy IBB
$167.50
+3.23 (+1.97%)
At Close: Jun 03, 2026
Key Stock Market ETFs Hanging Tough Amidst Volatility
04:52pm, Sunday, 28'th Jul 2024
Here we are, another week and another notch on the bull market belt. Last weekend, we were very bullish coming into this past week on Small Caps, Biotechnology and Regional Banks.
iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum
12:25pm, Sunday, 28'th Jul 2024
Biotechnology companies experienced an optimistic bullish cycle in 2020-2021, leading to outperformance of the Biotech index. But the cycle of interest rate increases taking place since 2022 has cause
CPI Data Sparks Rally in Biotech Stocks
08:32am, Monday, 15'th Jul 2024
The biotech sector has significantly lagged behind the overall market and its leading sector, technology, year-to-date. However, following the release of the CPI data on Thursday, the biotech sector,
The Biotechnology Sector ETF (IBB) Clears Price Resistance
12:58pm, Friday, 12'th Jul 2024
On June 24, 2024 I wrote a daily called, Biotechnology Sector IBB Breakout Comes To Life: “IBB sits just below the 200-WMA. Plus, he is in the middle of the weekly channel range.
Biotech Stocks 2024 Second Half Outlook - Buy Biotechs
07:00am, Tuesday, 09'th Jul 2024
Biotech indexes lagged broader market indexes in the first half of 2024, and trade at the same level as in early 2022. Biotech valuations are closely tied to the Fed's interest rate policy and are hig
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
10:52am, Tuesday, 02'nd Jul 2024
The biotechnology sector, represented by the iShares Biotechnology ETF NASDAQ: IBB, has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market, making
$IBB Biotechnology Sector ETF Breakout Comes To Life
11:01pm, Monday, 24'th Jun 2024
Over the weekend as we looked at the entire Economic Modern Family of stock market ETFs, we focused on Big Brother Biotechnology IBB as particularly intriguing. We wrote: “IBB sits just below the 20
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:21am, Wednesday, 05'th Jun 2024
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:21am, Thursday, 30'th May 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05
Why the Rest of 2024 Could Be Good for Investing in Biotech Stocks
07:00am, Friday, 24'th May 2024
Innovation has been a hallmark of biotechnology for decades and, despite some of the hardest sledding in many years, 2024 could be a bounce-back year for biotech stocks. The sector has suffered in thi
Fighting Obesity Using ETFs
03:32pm, Monday, 13'th May 2024
Weight loss has long been a challenge for many people, me included. Indeed, there are an estimated 1 billion individuals living with obesity, and the Obesity World Atlas estimates this could rise to 1
Will the Biotech Sector Shift From Lagger to Leader?
07:24am, Friday, 10'th May 2024
The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector ha
S&P 500's Best 3-Day Run in 2024: ETF Areas That Won
09:01am, Tuesday, 07'th May 2024
Wall Street was in great shape on Monday, with the S&P 500 experiencing its largest three-day rally of the year.
BIO-key International, Inc. Receives Notice of
04:59pm, Monday, 22'nd Apr 2024
HOLMDEL, N.J., April 22, 2024 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
09:27am, Wednesday, 10'th Apr 2024
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
